Akèy › Dematit atopik (Ekzema) › Washington
Etid klinik pou Dematit atopik (Ekzema) nan Washington, DC
11 etid pou Dematit atopik (Ekzema) ap chèche patisipan nan sit nan ak bò kote Washington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis
Ap rekriteFaz 1
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Natural History and Genetics of Food Allergy and Related Conditions
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
Ap rekriteFaz 2
- Novartis Investigative Site, Washington D.C.
Effects of Treatments on Atopic Dermatitis
Ap rekriteFaz 2Volontè an sante akeyi
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Metabolic Profiling of Immune Responses in Immune-mediated Diseases
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Studies of Skin Microbes in Healthy People and in People With Skin Conditions
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic Dermatitis
Ap rekriteFaz 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Cardamom and Topical Roseomonas in Atopic Dermatitis
Ap rekriteFaz 2
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
Ap rekriteFaz 3
- Maryland Allergy & Asthma Center /ID# 268032, Lanham · 11 mi lwen
A Biorepository of Multiple Allergic Diseases (MADREP) With Longitudinal Follow-Up
Ap rekriteEtid obsèvasyon
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Ap rekriteEtid obsèvasyon
- Galderma Investigational Site 8012, Glenn Dale · 13 mi lwen
Etid Dematit atopik (Ekzema) nan lòt vil
- New York City, NY13 etid
- Los Angeles, CA11 etid
- San Antonio, TX10 etid
- San Diego, CA10 etid
- Birmingham, AL9 etid
- Miami, FL9 etid
- Dallas, TX8 etid
- Huntington Beach, CA8 etid
- Sacramento, CA8 etid
- Troy, MI8 etid
- Indianapolis, IN7 etid
- Tampa, FL7 etid
Lòt etid nan Washington
- Kansè (tout kalite)58 etid
- Kansè Poumon ki pa ti selil55 etid
- Kansè nan tete46 etid
- Kansè Metastatik43 etid
- Kansè poumon41 etid
- Kansè pwostat38 etid
- Obèsite33 etid
- Kansè kolorektal29 etid
- Maladi kadyovaskilè28 etid
- Kansè vejik26 etid
- Leksemi mieloïd egi24 etid
- Kansè ovè23 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.